EA201691656A2 - Терапевтические способы с применением норибогаина и родственных соединений - Google Patents

Терапевтические способы с применением норибогаина и родственных соединений

Info

Publication number
EA201691656A2
EA201691656A2 EA201691656A EA201691656A EA201691656A2 EA 201691656 A2 EA201691656 A2 EA 201691656A2 EA 201691656 A EA201691656 A EA 201691656A EA 201691656 A EA201691656 A EA 201691656A EA 201691656 A2 EA201691656 A2 EA 201691656A2
Authority
EA
Eurasian Patent Office
Prior art keywords
noribogogine
related compounds
therapeutic ways
therapeutic
noribogaine
Prior art date
Application number
EA201691656A
Other languages
English (en)
Russian (ru)
Inventor
Лоуренс Фридхофф
Эмелин Мейллет
Хольгер Вейс
Original Assignee
Демеркс, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2014/019692 external-priority patent/WO2015126434A1/fr
Priority claimed from US14/195,822 external-priority patent/US9345711B2/en
Priority claimed from US14/485,514 external-priority patent/US20150231147A1/en
Application filed by Демеркс, Инк. filed Critical Демеркс, Инк.
Publication of EA201691656A2 publication Critical patent/EA201691656A2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Addiction (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EA201691656A 2014-02-18 2015-02-17 Терапевтические способы с применением норибогаина и родственных соединений EA201691656A2 (ru)

Applications Claiming Priority (23)

Application Number Priority Date Filing Date Title
US201461941387P 2014-02-18 2014-02-18
US201461941390P 2014-02-18 2014-02-18
US201461945746P 2014-02-27 2014-02-27
PCT/US2014/019692 WO2015126434A1 (fr) 2014-02-18 2014-02-28 Méthodes de traitement aigu et à long terme de la toxicomanie
US14/195,822 US9345711B2 (en) 2014-02-18 2014-03-03 Methods for acute and long-term treatment of drug addiction
US201461952733P 2014-03-13 2014-03-13
US201461952744P 2014-03-13 2014-03-13
US201461952731P 2014-03-13 2014-03-13
US201461952727P 2014-03-13 2014-03-13
US201461952738P 2014-03-13 2014-03-13
US201461952741P 2014-03-13 2014-03-13
US201462005847P 2014-05-30 2014-05-30
US201462005858P 2014-05-30 2014-05-30
US201462005841P 2014-05-30 2014-05-30
US201462005851P 2014-05-30 2014-05-30
US201462005855P 2014-05-30 2014-05-30
US14/292,632 US20150231146A1 (en) 2014-02-18 2014-05-30 Methods for acute and long-term treatment of drug addiction
US201462007346P 2014-06-03 2014-06-03
US201462024388P 2014-07-14 2014-07-14
US201462033538P 2014-08-05 2014-08-05
US201462035335P 2014-08-08 2014-08-08
US14/485,514 US20150231147A1 (en) 2014-02-18 2014-09-12 Methods for acute and long-term treatment of drug addiction
PCT/US2015/016186 WO2015126836A2 (fr) 2014-02-18 2015-02-17 Méthodes thérapeutiques faisant intervenir de la noribogaïne et des composés apparentés

Publications (1)

Publication Number Publication Date
EA201691656A2 true EA201691656A2 (ru) 2017-03-31

Family

ID=53879225

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201691656A EA201691656A2 (ru) 2014-02-18 2015-02-17 Терапевтические способы с применением норибогаина и родственных соединений

Country Status (10)

Country Link
EP (1) EP3107546A4 (fr)
JP (1) JP2017506244A (fr)
KR (1) KR20160124829A (fr)
CN (1) CN106413718A (fr)
AU (2) AU2015219172A1 (fr)
CA (2) CA3221251A1 (fr)
EA (1) EA201691656A2 (fr)
IL (1) IL247325A0 (fr)
TW (1) TW201534306A (fr)
WO (1) WO2015126836A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014143201A1 (fr) 2013-03-15 2014-09-18 Demerx, Inc. Procédé pour le traitement avec la noribogaïne de l'addiction de patients sous méthadone
US9561232B2 (en) 2014-02-18 2017-02-07 Demerx, Inc. Low dose noribogaine for treating nicotine addiction and preventing relapse of nicotine use
US9591978B2 (en) 2014-03-13 2017-03-14 Demerx, Inc. Methods and compositions for pre-screening patients for treatment with noribogaine
US9549935B2 (en) 2014-07-14 2017-01-24 Demerx, Inc. Methods and compositions for treating migraines using noribogaine
EP3915639B1 (fr) * 2014-11-26 2023-06-07 DemeRx, Inc. Procédés et compositions pour potentialiser l'action d'analgésiques opioïdes en utilisant des alcaloïdes de l'iboga

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE324897T1 (de) * 1994-07-25 2006-06-15 Nda Int Inc Verwendung von noribogain derivaten zur behandlung von chemischer abhängigkeit bei säugern
EP1327447B1 (fr) * 1997-09-04 2011-05-25 Novoneuron, Inc. Noribogaine utilisée pour le traitement de la douleur et de la toxomanie
US7220737B1 (en) * 1997-09-04 2007-05-22 Novoneuron, Inc Noribogaine in the treatment of pain and drug addiction
US20030153552A1 (en) * 2002-02-14 2003-08-14 Mash Deborah C. Method of treating chemical dependency in mammals and a composition therefor
MX2013000733A (es) * 2010-07-23 2013-05-30 Demerx Inc Composiciones de noribogaina.
WO2014143201A1 (fr) * 2013-03-15 2014-09-18 Demerx, Inc. Procédé pour le traitement avec la noribogaïne de l'addiction de patients sous méthadone

Also Published As

Publication number Publication date
KR20160124829A (ko) 2016-10-28
CA2977636A1 (fr) 2015-08-27
WO2015126836A2 (fr) 2015-08-27
CA2977636C (fr) 2024-01-02
AU2020267217A1 (en) 2020-12-03
EP3107546A2 (fr) 2016-12-28
AU2015219172A1 (en) 2016-09-29
CN106413718A (zh) 2017-02-15
EP3107546A4 (fr) 2017-10-25
TW201534306A (zh) 2015-09-16
JP2017506244A (ja) 2017-03-02
AU2020267217B2 (en) 2022-04-07
IL247325A0 (en) 2016-09-29
CA3221251A1 (fr) 2015-08-27

Similar Documents

Publication Publication Date Title
EA201990665A1 (ru) Регуляторы hpk1 на основе производных пиразолопиридина и их применение для лечения рака
EA201691872A1 (ru) Гетероциклические соединения для применения в лечении pi3k-гамма-опосредованных расстройств
EA201692436A1 (ru) Медицинское применение
EA201592250A1 (ru) Пиразолопирролидиновые производные и их применение в лечение заболеваний
EA201991484A1 (ru) Лекарственные формы энзалутамида
MX2016010504A (es) Metodos para el tratamiento de pacientes con hipercolesterolemia que no esta controlada adecuadamente por una terapia con estatinas de dosis moderada referencia cruzada a solicitudes relacionas.
WO2015054619A8 (fr) Utilisation d'un inhibiteur de pcsk9 pour traiter l'hyperlipidémie
EA201591290A2 (ru) Креноланиб для лечения пролиферативных расстройств, связанных с мутацией flt3
PH12017500493A1 (en) Combination therapy
PH12016502352A1 (en) Pharmaceutical composition
PH12016502353A1 (en) Pharmaceutical composition
EA201892265A1 (ru) Способы лечения офтальмологических заболеваний
MD3416631T2 (ro) Agenți terapeutici pentru bolile neurodegenerative
MX2018006247A (es) Metodos para tratar la enfermedad de alzheimer y trastornos relacionados.
MX2021002321A (es) Nuevos metodos.
EA201691656A2 (ru) Терапевтические способы с применением норибогаина и родственных соединений
EA201691918A1 (ru) Фармацевтические составы ингибитора киназ семейства raf, способы их получения и способы их применения
WO2016029136A8 (fr) 3-amidobenzamides et leurs utilisations pour augmenter les taux cellulaires d'a3g
EA201692111A1 (ru) Фармацевтические композиции, содержащие данириксин, для лечения инфекционных заболеваний
EA201792571A1 (ru) Терапевтическое применение l-4-хлорокинуренина
EA201792264A1 (ru) Способы лечения воспалительных заболеваний
EA201370230A1 (ru) Новые ингибиторы rock
EA201691058A1 (ru) Производные пирролопирролона и их применение для лечения заболеваний
PH12016502480A1 (en) Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases
EA201792265A1 (ru) Способы лечения сердечно-сосудистых заболеваний